Robert Arch is a seasoned pharma and biotech executive with a strong background in R&D and clinical development. Currently serving as a Pharma and Biotech Executive, they have held key leadership roles, including President and CEO of OncoSec Medical Incorporated, where they successfully restructured the organization and secured significant funding. Previously, Arch served as Senior Vice President at Elpiscience Biopharmaceuticals and held various directorial positions at Pfizer and Takeda, contributing to advancements in liver disease and neuroinflammation research. Arch possesses a PhD from The Julius Maximilians University of Würzburg and has a robust foundation in immunology and liver disease, coupled with extensive expertise in transitioning assets from pre-clinical to clinical programs.
This person is not in the org chart
This person is not in any teams
This person is not in any offices